Drug information for PERPHENAZINE
Form
Dosage
Status
Therapeutic Equivalence
Active Ingred
Ref.
Sponsor
Document
CONCENTRATE; ORAL
16MG/5ML
Discontinued
PERPHENAZINE
Perphenazine
PHARM ASSOC
40360
2001-05-25 Letter
TABLET; ORAL
16MG
Prescription
AB
PERPHENAZINE
Perphenazine
VINTAGE PHARMS
40226
2004-06-14 Letter
2004-06-14 Label
2003-07-30 Review
TABLET; ORAL
2MG
Prescription
AB
PERPHENAZINE
Perphenazine
VINTAGE PHARMS
"
TABLET; ORAL
4MG
Prescription
AB
PERPHENAZINE
Perphenazine
VINTAGE PHARMS
"
TABLET; ORAL
8MG
Prescription
AB
PERPHENAZINE
Perphenazine
VINTAGE PHARMS
"
TABLET; ORAL
8MG
Discontinued
PERPHENAZINE
Perphenazine
IVAX PHARMS
89456
TABLET; ORAL
16MG
Discontinued
PERPHENAZINE
Perphenazine
IVAX PHARMS
89457
TABLET; ORAL
2MG
Prescription
AB
PERPHENAZINE
Perphenazine
SANDOZ
89683
TABLET; ORAL
4MG
Prescription
AB
PERPHENAZINE
Perphenazine
SANDOZ
89684
TABLET; ORAL
8MG
Prescription
AB
PERPHENAZINE
Perphenazine
SANDOZ
89685
TABLET; ORAL
16MG
Prescription
AB (Reference Drug)
PERPHENAZINE
Perphenazine
SANDOZ
89686
TABLET; ORAL
2MG
Discontinued
PERPHENAZINE
Perphenazine
IVAX PHARMS
89707
TABLET; ORAL
4MG
Discontinued
PERPHENAZINE
Perphenazine
IVAX PHARMS
89708
Drug Adverse Effects information for PERPHENAZINE
Role code
Indications
Reaction
# Reports
SS
AGITATION
ILEUS PARALYTIC
1
SS
DEMENTIA
CHEST INJURY
1
SS
DEMENTIA
CONFUSIONAL STATE
1
SS
DEMENTIA
EXCORIATION
1
SS
DEMENTIA
FALL
1
SS
DEMENTIA
HALLUCINATION
1
SS
DEMENTIA
HEAD INJURY
1
SS
DEPRESSION
CHEST INJURY
1
SS
DEPRESSION
CONFUSIONAL STATE
1
SS
DEPRESSION
EXCORIATION
1
SS
DEPRESSION
FALL
1
SS
DEPRESSION
HALLUCINATION
1
SS
DEPRESSION
HEAD INJURY
1
SS
EXTRAPYRAMIDAL DISORDER
ILEUS PARALYTIC
1
SS
PRODUCT USED FOR UNKNOWN INDICATION
COMPLETED SUICIDE
3
SS
PRODUCT USED FOR UNKNOWN INDICATION
ILEUS PARALYTIC
4
SS
PRODUCT USED FOR UNKNOWN INDICATION
PLEUROTHOTONUS
24
C
ANXIETY
DEPRESSED LEVEL OF CONSCIOUSNESS
1
C
ANXIETY
PERSONALITY CHANGE
1
C
ASTHMA
ANAEMIA
2
C
ASTHMA
C-REACTIVE PROTEIN INCREASED
2
C
ASTHMA
CANDIDIASIS
2
C
ASTHMA
DRUG HYPERSENSITIVITY
2
C
ASTHMA
EOSINOPHIL COUNT INCREASED
2
C
ASTHMA
ERYTHEMA
2
C
ASTHMA
ERYTHEMA MIGRANS
2
C
ASTHMA
HAEMATOCHEZIA
2
C
ASTHMA
HAEMATOCRIT DECREASED
2
C
ASTHMA
HISTONE ANTIBODY POSITIVE
2
C
ASTHMA
LOGORRHOEA
2
C
ASTHMA
MUSCLE MASS
2
C
ASTHMA
MUSCLE TWITCHING
2
C
ASTHMA
OEDEMA PERIPHERAL
2
C
ASTHMA
PRURITUS
2
C
ASTHMA
RED BLOOD CELL SEDIMENTATION RATE INCREASED
2
C
ASTHMA
SKIN REACTION
2
C
ASTHMA
TRANSFERRIN INCREASED
2
C
BIPOLAR DISORDER
ADVERSE EVENT
1
C
BIPOLAR DISORDER
BLOOD CHOLESTEROL INCREASED
1
C
BIPOLAR DISORDER
DIABETIC COMA
2
C
BIPOLAR DISORDER
GLAUCOMA
1
C
BIPOLAR DISORDER
HYPERGLYCAEMIA
1
C
BIPOLAR DISORDER
LIVER FUNCTION TEST ABNORMAL
2
C
BIPOLAR DISORDER
TYPE 2 DIABETES MELLITUS
2
C
BIPOLAR DISORDER
WEIGHT INCREASED
1
C
BIPOLAR I DISORDER
DIABETIC COMA
2
C
BIPOLAR I DISORDER
LIVER FUNCTION TEST ABNORMAL
2
C
BIPOLAR I DISORDER
TYPE 2 DIABETES MELLITUS
2
C
CONVULSION PROPHYLAXIS
EOSINOPHIL COUNT INCREASED
3
C
CONVULSION PROPHYLAXIS
GRAND MAL CONVULSION
3
C
CONVULSION PROPHYLAXIS
LYMPHOCYTE COUNT DECREASED
3
C
CONVULSION PROPHYLAXIS
MONOCYTE COUNT INCREASED
3
C
CONVULSION PROPHYLAXIS
SALIVARY HYPERSECRETION
3
C
ERECTILE DYSFUNCTION
ERECTILE DYSFUNCTION
1
C
HYPOTHYROIDISM
ANAEMIA
1
C
HYPOTHYROIDISM
C-REACTIVE PROTEIN INCREASED
1
C
HYPOTHYROIDISM
CANDIDIASIS
1
C
HYPOTHYROIDISM
DRUG HYPERSENSITIVITY
1
C
HYPOTHYROIDISM
EOSINOPHIL COUNT INCREASED
1
C
HYPOTHYROIDISM
ERYTHEMA
1
C
HYPOTHYROIDISM
ERYTHEMA MIGRANS
1
C
HYPOTHYROIDISM
HAEMATOCHEZIA
1
C
HYPOTHYROIDISM
HAEMATOCRIT DECREASED
1
C
HYPOTHYROIDISM
HISTONE ANTIBODY POSITIVE
1
C
HYPOTHYROIDISM
LOGORRHOEA
1
C
HYPOTHYROIDISM
MUSCLE MASS
1
C
HYPOTHYROIDISM
MUSCLE TWITCHING
1
C
HYPOTHYROIDISM
OEDEMA PERIPHERAL
1
C
HYPOTHYROIDISM
PRURITUS
1
C
HYPOTHYROIDISM
RED BLOOD CELL SEDIMENTATION RATE INCREASED
1
C
HYPOTHYROIDISM
SKIN REACTION
1
C
HYPOTHYROIDISM
TRANSFERRIN INCREASED
1
C
LOCALISED INFECTION
BLOOD CALCIUM DECREASED
2
C
LOCALISED INFECTION
BLOOD CREATININE INCREASED
2
C
LOCALISED INFECTION
BLOOD UREA INCREASED
2
C
LOCALISED INFECTION
EOSINOPHIL COUNT INCREASED
2
C
LOCALISED INFECTION
FUNGAL INFECTION
2
C
LOCALISED INFECTION
HEADACHE
2
C
LOCALISED INFECTION
NEUTROPHIL COUNT INCREASED
2
C
LOCALISED INFECTION
PROTEIN TOTAL DECREASED
2
C
LOCALISED INFECTION
PROTEIN URINE PRESENT
2
C
LOCALISED INFECTION
PYREXIA
2
C
LOCALISED INFECTION
RENAL FAILURE ACUTE
2
C
LOCALISED INFECTION
RESPIRATORY TRACT INFECTION
2
C
LOCALISED INFECTION
TUBULOINTERSTITIAL NEPHRITIS
2
C
LOCALISED INFECTION
URINARY TRACT INFECTION
2
C
LOCALISED INFECTION
VIRAL INFECTION
2
C
LOCALISED INFECTION
WHITE BLOOD CELL COUNT INCREASED
2
C
OESOPHAGITIS
ANAEMIA
1
C
OESOPHAGITIS
C-REACTIVE PROTEIN INCREASED
1
C
OESOPHAGITIS
CANDIDIASIS
1
C
OESOPHAGITIS
DRUG HYPERSENSITIVITY
1
C
OESOPHAGITIS
EOSINOPHIL COUNT INCREASED
1
C
OESOPHAGITIS
ERYTHEMA
1
C
OESOPHAGITIS
ERYTHEMA MIGRANS
1
C
OESOPHAGITIS
HAEMATOCHEZIA
1
C
OESOPHAGITIS
HAEMATOCRIT DECREASED
1
C
OESOPHAGITIS
HISTONE ANTIBODY POSITIVE
1
C
OESOPHAGITIS
LOGORRHOEA
1
C
OESOPHAGITIS
MUSCLE MASS
1
C
OESOPHAGITIS
MUSCLE TWITCHING
1
C
OESOPHAGITIS
OEDEMA PERIPHERAL
1
C
OESOPHAGITIS
PRURITUS
1
C
OESOPHAGITIS
RED BLOOD CELL SEDIMENTATION RATE INCREASED
1
C
OESOPHAGITIS
SKIN REACTION
1
C
OESOPHAGITIS
TRANSFERRIN INCREASED
1
C
PSYCHOTIC DISORDER
ARTHRALGIA
1
C
PSYCHOTIC DISORDER
INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION
1
C
PSYCHOTIC DISORDER
SOMNOLENCE
1
C
PSYCHOTIC DISORDER
UNDERDOSE
1
C
SALIVARY HYPERSECRETION
EOSINOPHIL COUNT INCREASED
3
C
SALIVARY HYPERSECRETION
GRAND MAL CONVULSION
3
C
SALIVARY HYPERSECRETION
LYMPHOCYTE COUNT DECREASED
3
C
SALIVARY HYPERSECRETION
MONOCYTE COUNT INCREASED
3
C
SALIVARY HYPERSECRETION
SALIVARY HYPERSECRETION
3
C
SCHIZOAFFECTIVE DISORDER
ARTHRALGIA
1
C
SCHIZOAFFECTIVE DISORDER
BALLISMUS
1
C
SCHIZOAFFECTIVE DISORDER
CHOREOATHETOSIS
1
C
SCHIZOAFFECTIVE DISORDER
DYSARTHRIA
1
C
SCHIZOAFFECTIVE DISORDER
DYSKINESIA
1
C
SCHIZOAFFECTIVE DISORDER
DYSTONIA
1
C
SCHIZOAFFECTIVE DISORDER
GAIT DISTURBANCE
1
C
SCHIZOAFFECTIVE DISORDER
GRIMACING
1
C
SCHIZOAFFECTIVE DISORDER
INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION
1
C
SCHIZOAFFECTIVE DISORDER
MENTAL DISORDER
1
C
SCHIZOAFFECTIVE DISORDER
MUSCULOSKELETAL DISCOMFORT
1
C
SCHIZOAFFECTIVE DISORDER
PROTRUSION TONGUE
1
C
SCHIZOAFFECTIVE DISORDER
SOMNOLENCE
1
C
SCHIZOAFFECTIVE DISORDER
TARDIVE DYSKINESIA
1
C
SCHIZOAFFECTIVE DISORDER
TONGUE DISORDER
1
C
SCHIZOAFFECTIVE DISORDER
UNDERDOSE
1
C
SCHIZOPHRENIA
ABDOMINAL DISTENSION
1
C
SCHIZOPHRENIA
AGGRESSION
9
C
SCHIZOPHRENIA
AGITATION
10
C
SCHIZOPHRENIA
ANAEMIA
1
C
SCHIZOPHRENIA
ANGER
9
C
SCHIZOPHRENIA
ATELECTASIS
9
C
SCHIZOPHRENIA
BALLISMUS
1
C
SCHIZOPHRENIA
C-REACTIVE PROTEIN INCREASED
10
C
SCHIZOPHRENIA
CANDIDIASIS
1
C
SCHIZOPHRENIA
CARDIAC MURMUR
1
C
SCHIZOPHRENIA
CHOREOATHETOSIS
1
C
SCHIZOPHRENIA
DEATH
1
C
SCHIZOPHRENIA
DIABETES MELLITUS
1
C
SCHIZOPHRENIA
DRUG HYPERSENSITIVITY
1
C
SCHIZOPHRENIA
DYSARTHRIA
1
C
SCHIZOPHRENIA
DYSKINESIA
1
C
SCHIZOPHRENIA
DYSTONIA
1
C
SCHIZOPHRENIA
EOSINOPHIL COUNT INCREASED
19
C
SCHIZOPHRENIA
ERYTHEMA
1
C
SCHIZOPHRENIA
ERYTHEMA MIGRANS
1
C
SCHIZOPHRENIA
GAIT DISTURBANCE
1
C
SCHIZOPHRENIA
GRAND MAL CONVULSION
18
C
SCHIZOPHRENIA
GRIMACING
1
C
SCHIZOPHRENIA
HAEMATOCHEZIA
1
C
SCHIZOPHRENIA
HAEMATOCRIT DECREASED
1
C
SCHIZOPHRENIA
HEPATIC FUNCTION ABNORMAL
9
C
SCHIZOPHRENIA
HISTONE ANTIBODY POSITIVE
1
C
SCHIZOPHRENIA
ILEUS PARALYTIC
1
C
SCHIZOPHRENIA
IRRITABILITY
9
C
SCHIZOPHRENIA
LOGORRHOEA
1
C
SCHIZOPHRENIA
LYMPHOCYTE COUNT DECREASED
18
C
SCHIZOPHRENIA
MENTAL DISORDER
1
C
SCHIZOPHRENIA
MONOCYTE COUNT INCREASED
18
C
SCHIZOPHRENIA
MUSCLE MASS
1
C
SCHIZOPHRENIA
MUSCLE TWITCHING
1
C
SCHIZOPHRENIA
MUSCULOSKELETAL DISCOMFORT
1
C
SCHIZOPHRENIA
NEUTROPHIL COUNT DECREASED
9
C
SCHIZOPHRENIA
OEDEMA PERIPHERAL
1
C
SCHIZOPHRENIA
PLATELET COUNT DECREASED
9
C
SCHIZOPHRENIA
PLEURAL EFFUSION
9
C
SCHIZOPHRENIA
PLEURISY
9
C
SCHIZOPHRENIA
PROTEINURIA
1
C
SCHIZOPHRENIA
PROTRUSION TONGUE
1
C
SCHIZOPHRENIA
PRURITUS
1
C
SCHIZOPHRENIA
PYREXIA
9
C
SCHIZOPHRENIA
RED BLOOD CELL SEDIMENTATION RATE INCREASED
1
C
SCHIZOPHRENIA
SALIVARY HYPERSECRETION
18
C
SCHIZOPHRENIA
SKIN REACTION
1
C
SCHIZOPHRENIA
TARDIVE DYSKINESIA
1
C
SCHIZOPHRENIA
THERAPEUTIC RESPONSE DECREASED
1
C
SCHIZOPHRENIA
THIRST
9
C
SCHIZOPHRENIA
TONGUE DISORDER
1
C
SCHIZOPHRENIA
TRANSFERRIN INCREASED
1
C
SCHIZOPHRENIA
WHITE BLOOD CELL COUNT DECREASED
10
C
SCHIZOPHRENIA, PARANOID TYPE
EOSINOPHIL COUNT INCREASED
3
C
SCHIZOPHRENIA, PARANOID TYPE
GRAND MAL CONVULSION
3
C
SCHIZOPHRENIA, PARANOID TYPE
LYMPHOCYTE COUNT DECREASED
3
C
SCHIZOPHRENIA, PARANOID TYPE
MONOCYTE COUNT INCREASED
3
C
SCHIZOPHRENIA, PARANOID TYPE
SALIVARY HYPERSECRETION
3
C
SLEEP DISORDER THERAPY
DIABETIC COMA
2
C
SLEEP DISORDER THERAPY
LIVER FUNCTION TEST ABNORMAL
2
C
SLEEP DISORDER THERAPY
TYPE 2 DIABETES MELLITUS
2
C
TYPE 2 DIABETES MELLITUS
ANAEMIA
2
C
TYPE 2 DIABETES MELLITUS
C-REACTIVE PROTEIN INCREASED
2
C
TYPE 2 DIABETES MELLITUS
CANDIDIASIS
2
C
TYPE 2 DIABETES MELLITUS
DRUG HYPERSENSITIVITY
2
C
TYPE 2 DIABETES MELLITUS
EOSINOPHIL COUNT INCREASED
2
C
TYPE 2 DIABETES MELLITUS
ERYTHEMA
2
C
TYPE 2 DIABETES MELLITUS
ERYTHEMA MIGRANS
2
C
TYPE 2 DIABETES MELLITUS
HAEMATOCHEZIA
2
C
TYPE 2 DIABETES MELLITUS
HAEMATOCRIT DECREASED
2
C
TYPE 2 DIABETES MELLITUS
HISTONE ANTIBODY POSITIVE
2
C
TYPE 2 DIABETES MELLITUS
LOGORRHOEA
2
C
TYPE 2 DIABETES MELLITUS
MUSCLE MASS
2
C
TYPE 2 DIABETES MELLITUS
MUSCLE TWITCHING
2
C
TYPE 2 DIABETES MELLITUS
OEDEMA PERIPHERAL
2
C
TYPE 2 DIABETES MELLITUS
PRURITUS
2
C
TYPE 2 DIABETES MELLITUS
RED BLOOD CELL SEDIMENTATION RATE INCREASED
2
C
TYPE 2 DIABETES MELLITUS
SKIN REACTION
2
C
TYPE 2 DIABETES MELLITUS
TRANSFERRIN INCREASED
2
Ads by Google